Revamped Structure Features Two Key Segments (Americas CRO and Europe CRO)

Argenta, the leading animal health pharmaceutical services company, today announced the strategic realignment of its CRO platform, effectively immediately.

Over the past several years, Argenta’s CRO platform has experienced tremendous momentum through both strong organic growth as well as through a series of highly strategic and complementary acquisitions. Today, Argenta has a comprehensive set of capabilities including regulatory, pre-clinical, and clinical CRO services. We believe this realignment of the CRO business is a natural next step in further strengthening our customer value proposition and integrating our various operations—ultimately enhancing our ability to more seamlessly serve the entire end-to-end R&D and product development journey within the animal health industry.

Argenta’s CRO platform will be organized into two key segments under the leadership of two highly experienced Argenta executives who possess extremely strong track records of performance, quality, customer trust, and driving growth:

• Americas CRO: Charley Cull will become the Head of Americas CRO. Charley was most recently the Head of Product Development Services and a member of the senior leadership team at Midwest Veterinary Services which was acquired by Argenta in 2023. In his new role, Charley will have full responsibility for the CRO platform in the Americas. He will also be maintaining his existing role as the Head of Product Development Services at Argenta.
• Europe CRO: Klaus Hellmann will become the Head of Europe CRO. Klaus was most recently Argenta’s Chief Veterinary Officer with Business Development responsibilities in Europe and Asia for the CRO business, and previously the founder / CEO of Klifovet which was acquired by Argenta in 2021. In his new role, Klaus will have full responsibility for the CRO platform in Europe.

Charley and Klaus will both be members of the Executive Leadership Team and oversee their respective organizations in the CRO business as well as work together to drive better coordination globally, reporting directly to the CEO.

“I am incredibly excited to announce the next chapter of Argenta’s CRO platform. We believe this strategic realignment will help enhance our ability as a Company to better serve the accelerating need for our core services. I am thrilled to welcome both Charley and Klaus into their new roles, and look forward to working with them to further our mission and help realize our full potential in the animal health industry,” said Stephan Kutzer, Interim CEO and Board Member at Argenta.

‍

About Argenta‍

Argenta is a global animal health services company, supporting companies big and small to develop and manufacture products that contribute to the health and well-being of animals. From “molecule to market”, our trusted, innovative solutions cover every stage of product development, and we are trusted by the world’s top animal health companies – who return to Argenta for our unparalleled, comprehensive support. For more information, please visit www.argentaglobal.com.

‍

Press Contact‍

Annemieke de Keijzer
Global Head of Communications and Marketing
globalcommunications@argentaglobal.com

‍